ChemicalBook > CAS DataBase List > Alflutinib

Alflutinib

Product Name
Alflutinib
CAS No.
1869057-83-9
Chemical Name
Alflutinib
Synonyms
Aflutinib;ASK120067;Alflutinib;Firmonertinib;Capsaicin Impurity 17;Firmonertinib Alflutinib;Alflutinib, 10 mM in DMSO;Alflutinib (Firmonertinib);AST2818;AST-2818;ASK120067;Alflutinib,inhibit,esistant mutation,T790M,EGFR,AST 2818,Furmonertinib,Inhibitor,ErbB-1,NSCLC,cancer,Epidermal growth factor receptor,AST-2818,HER1
CBNumber
CB84844457
Molecular Formula
C28H31F3N8O2
Formula Weight
568.61
MOL File
1869057-83-9.mol
More
Less

Alflutinib Property

Density 
1.29±0.1 g/cm3(Predicted)
form 
Solid
pka
11+-.0.70(Predicted)
color 
White to off-white
InChIKey
GHKOONMJXNWOIW-UHFFFAOYSA-N
SMILES
CN1C2=CC=CC=C2C(C2C=CN=C(NC3C=C(NC(=O)C=C)C(N(C)CCN(C)C)=NC=3OCC(F)(F)F)N=2)=C1
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Biorbyt Ltd
Product number
orb573225
Product name
Alflutinib
Purity
>98%
Packaging
100mg
Price
$1283.5
Updated
2021/12/16
Biorbyt Ltd
Product number
orb573225
Product name
Alflutinib
Purity
>98%
Packaging
250mg
Price
$2395.3
Updated
2021/12/16
Biorbyt Ltd
Product number
orb573225
Product name
Alflutinib
Purity
>98%
Packaging
1g
Price
$4766.8
Updated
2021/12/16
DC Chemicals
Product number
DC12389
Product name
Alflutinib
Purity
>98%
Packaging
100mg
Price
$850
Updated
2021/12/16
DC Chemicals
Product number
DC12389
Product name
Alflutinib
Purity
>98%
Packaging
1g
Price
$3200
Updated
2021/12/16
More
Less

Alflutinib Chemical Properties,Usage,Production

Uses

Firmonertinib (Alflutinib; Furmonertinib) is an orally active, mutant-selective, and highly brain penetrant EGFR inhibitor. Firmonertinib inhibits EGFR active mutations as well as the T790M acquired resistant mutation. Firmonertinib has the potential for the research of cancer diseases, especially advanced non-small cell lung cancer (NSCLC) with EGFR ex20ins mutation[1].

Mechanism of action

As a third-generation EGFR TKI, Alflutinib can irreversibly bind to the EGFR protein, especially to tumor cells carrying the T790M drug-resistant mutation. This specific binding helps reduce damage to normal cells while effectively inhibiting the proliferation of tumor cells.

Synthesis

Arylation of the indole prepared the chloropyridine 21.7, which was then reacted with the aniline 21.4 in the presence of excess p-toluenesulfonic acid to produce 21.8 (see Figure 7.3.2). The second SNAr reaction used the diamine 21.9, which was coprecipitated with water in DMF to give the amine 21.10 in 77% yield over a two-step reaction. Reduction of the nitro group using sodium sulfite gave the corresponding amine under metal-free and mild conditions. The crude aniline was then converted to the dihydrochloride salt 21.11, which was isolated as a solid in high purity (99.8%) and yield (94%) after slurrying in methanol and ethanol. Finally, a two-step approach was used to install the α,β-unsaturated amide, as opposed to the earlier route that used acryloyl chloride directly. The acylation reaction used the chloroacyl chloride 21.12 to give the alkyl chloride 21.13, which was isolated by filtration. Subsequently, an elimination reaction was carried out with triethylamine at reflux in acetonitrile to prepare alflutinib (21) in 93% yield and 99.2% purity.

IC 50

EGFR

References

[1] Y. Shi, et al. P2.03-028 Third Generation EGFR Inhibitor AST2818 (Alflutinib) in NSCLC Patients with EGFR T790M Mutation: A phase1/2 Multi-Center Clinical Trial.
[2] Alexander I. Spira, et al. FURVENT: Phase 3 trial of furmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004). Journal of Clinical Oncology. Volume 42, Number 16_suppl.

Alflutinib Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Alflutinib Suppliers

CAREBIO PHARMA
Tel
18501057619 18501057619
Email
jackyfan@rebornpharma.com
Country
China
ProdList
274
Advantage
58
Guangzhou Isun Pharmaceutical Co., Ltd
Tel
020-39119399 18927568969
Fax
020-39119999
Email
isunpharm@qq.com
Country
China
ProdList
4769
Advantage
55
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4817
Advantage
55
Shanghai Send Pharmaceutical Technology Co., Ltd.
Tel
50266790 18317173152
Fax
QQ3382968513
Email
Hailey@shsendpharm.com
Country
China
ProdList
905
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
86249
Advantage
60
Shanghai Rechem science Co., Ltd.
Tel
021-31433387 15618786686
Fax
QQ:1369748377
Email
sales@rechemscience.com
Country
China
ProdList
2988
Advantage
58
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Fax
21-5161 9052
Email
Sales@ATKchemical.com
Country
China
ProdList
9505
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32467
Advantage
58
Zhejiang J&C Biological Technology Co.,Limited
Tel
+1-2135480471 +1-2135480471;
Email
sales@sarms4muscle.com
Country
China
ProdList
10473
Advantage
58

1869057-83-9, AlflutinibRelated Search:


  • Alflutinib
  • ASK120067
  • AST2818;AST-2818;ASK120067
  • 2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-6-(2,2,2-trifluoroethoxy)-3-pyridinyl]-
  • Alflutinib,inhibit,esistant mutation,T790M,EGFR,AST 2818,Furmonertinib,Inhibitor,ErbB-1,NSCLC,cancer,Epidermal growth factor receptor,AST-2818,HER1
  • Firmonertinib Alflutinib
  • N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)prop-2-enamide
  • Capsaicin Impurity 17
  • Alflutinib, 10 mM in DMSO
  • Alflutinib (Firmonertinib)
  • Aflutinib
  • Firmonertinib
  • 1869057-83-9
  • C28H31F3N8O2